Evidence map›Paper›PMID 27534554›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Blood-Borne Lipopolysaccharide Is Rapidly Eliminated by Liver Sinusoidal Endothelial Cells via High-Density Lipoprotein.

Zhili Yao, Jessica M Mates, Alana M Cheplowitz, Lindsay P Hammer, Andrei Maiseyeu, Gary S Phillips, Mark D Wewers, Murugesan V S Rajaram, John M Robinson, Clark L Anderson and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 148 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. A mitochondria-targeted HRedox biology · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Microenvironmental determinants of endothelial cell heterogeneity.Nature reviews. Molecular cell biology · 2025
    Review
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Zhili YaoDepartment of Internal Medicine, The Ohio State University, Columbus, OH 43210;
Jessica M MatesDepartment of Internal Medicine, The Ohio State University, Columbus, OH 43210;
Alana M CheplowitzDepartment of Internal Medicine, The Ohio State University, Columbus, OH 43210;
Lindsay P HammerDepartment of Internal Medicine, The Ohio State University, Columbus, OH 43210;
Andrei MaiseyeuDivision of Cardiovascular Medicine, Department of Medicine, University of Maryland, Baltimore, MD 21201;
Gary S PhillipsDepartment of Biostatistics, The Ohio State University, Columbus, OH 43210;
Mark D WewersDepartment of Internal Medicine, The Ohio State University, Columbus, OH 43210;ORCID 0000-0002-7079-5633
Murugesan V S RajaramDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210; and.ORCID 0000-0002-1515-1122
John M RobinsonDepartment of Physiology and Cell Biology, The Ohio State University, Columbus, OH 43210.
Clark L AndersonDepartment of Internal Medicine, The Ohio State University, Columbus, OH 43210;
Latha P GanesanDepartment of Internal Medicine, The Ohio State University, Columbus, OH 43210; Ganesan.Prabha@osumc.edu.ORCID 0000-0002-4236-6620
The Ohio State University · USUniversity of Maryland, Baltimore · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
FcgRIIb protects fetus from allograft rejectionR01HD059912 · NICHD · OHIO STATE UNIVERSITY · PI ANDERSON, CLARK L · 2009 to 2013
$2.0M
Probing Cardiovascular Actions of GLP-1 Using NanoparticlesR01HL130516 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI MAISEYEU, ANDREI · 2016 to 2020
$1.9M
Immune Complex Elimination by Sinusoid Endothelial FcgRIIb: Mechanism and DiseaseR01AR066330 · NIAMS · OHIO STATE UNIVERSITY · PI ANDERSON, CLARK L, GANESAN, LATHA PRABHA · 2014 to 2018
$1.7M
NCI NIH HHS P30 CA016058NHLBI NIH HHS R01 HL130516NIAMS NIH HHS R01 AR066330NICHD NIH HHS R01 HD059912
6 · The paper itself

Abstract

During Gram-negative bacterial infections, excessive LPS induces inflammation and sepsis via action on immune cells. However, the bulk of LPS can be cleared from circulation by the liver. Liver clearance is thought to be a slow process mediated exclusively by phagocytic resident macrophages, Kupffer cells (KC). However, we discovered that LPS disappears rapidly from the circulation, with a half-life of 2-4 min in mice, and liver eliminates about three quarters of LPS from blood circulation. Using microscopic techniques, we found that ∼75% of fluor-tagged LPS in liver became associated with liver sinusoidal endothelial cells (LSEC) and only ∼25% with KC. Notably, the ratio of LSEC-KC-associated LPS remained unchanged 45 min after infusion, indicating that LSEC independently processes the LPS. Most interestingly, results of kinetic analysis of LPS bioactivity, using modified limulus amebocyte lysate assay, suggest that recombinant factor C, an LPS binding protein, competitively inhibits high-density lipoprotein (HDL)-mediated LPS association with LSEC early in the process. Supporting the previous notion, 3 min postinfusion, 75% of infused fluorescently tagged LPS-HDL complex associates with LSEC, suggesting that HDL facilitates LPS clearance. These results lead us to propose a new paradigm of LSEC and HDL in clearing LPS with a potential to avoid inflammation during sepsis.

Indexed as

Acute-Phase ProteinsAnimalsCarrier ProteinsEndothelial CellsGram-Negative Bacterial InfectionsHalf-LifeInflammationKineticsKupffer CellsLipopolysaccharide-Binding ProteinLipopolysaccharidesLipoproteins, HDLLiverMembrane GlycoproteinsMiceSepsisAcute-Phase ProteinsCarrier ProteinsLipopolysaccharide-Binding ProteinLipopolysaccharidesLipoproteins, HDLMembrane Glycoproteins

Identifiers

PMID27534554
PMCPMC5010928
OpenAlexW2516355868

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.